Source:http://linkedlifedata.com/resource/pubmed/id/19674474
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:dateCreated |
2009-9-8
|
pubmed:abstractText |
Liver cancer is a common malignancy with a high mortality rate. Given the poor prognosis associated with this cancer, many patients seek additional therapies that may improve quality of life or survival. Several Traditional Chinese Medicines (TCM) have been evaluated in clinical trials, but little is known about them outside of China.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
1756-9966
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:volume |
28
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
112
|
pubmed:meshHeading |
pubmed-meshheading:19674474-Carcinoma, Hepatocellular,
pubmed-meshheading:19674474-China,
pubmed-meshheading:19674474-Combined Modality Therapy,
pubmed-meshheading:19674474-Drugs, Chinese Herbal,
pubmed-meshheading:19674474-Humans,
pubmed-meshheading:19674474-Liver Neoplasms,
pubmed-meshheading:19674474-Medicine, Chinese Traditional,
pubmed-meshheading:19674474-Phytotherapy
|
pubmed:year |
2009
|
pubmed:articleTitle |
Traditional Chinese Medicines in the treatment of hepatocellular cancers: a systematic review and meta-analysis.
|
pubmed:affiliation |
Shanghai Hospital #4, Shanghai, PR China. pwu@ccnm.edu
|
pubmed:publicationType |
Journal Article,
Review,
Research Support, Non-U.S. Gov't,
Meta-Analysis
|